Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New injection aims to shed pounds: early trial recruits 150 volunteers

NCT ID NCT07476118

First seen Mar 21, 2026 · Last updated Jun 18, 2026 · Updated 13 times

Summary

This early-stage study tests a new drug called brenipatide in 150 healthy adults with overweight or obesity. Participants receive injections under the skin to see how different doses affect body weight and safety. The study lasts about 42 weeks and aims to find out if the drug can help control weight without causing serious side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fortrea Clinical Research Unit

    RECRUITING

    Dallas, Texas, 75247, United States

    Contact Phone: •••-•••-••••

    Contact

  • Fortrea Clinical Research Unit - Daytona Beach

    RECRUITING

    Daytona Beach, Florida, 32117-5116, United States

    Contact Phone: •••-•••-••••

    Contact

  • Fortrea Clinical Research Unit Inc. - Madison

    RECRUITING

    Madison, Wisconsin, 53704, United States

    Contact Phone: •••-•••-••••

    Contact

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.